Eagle Genomics helps steer the UK's Microbiome Strategy Roadmap

The UK's KTN (Knowledge Transfer Network) Microbiome Innovation Network has today published its Microbiome Strategy Roadmap, which includes contributions from the UK's leading microbiome voices, including Eagle Genomics.

The Microbiome Strategy Roadmap reviews the landscape of microbiome science and innovation within the UK. With the publication of the strategic roadmap document, the KTN will raise the visibility of the UK’s world leading microbiome science and enable translation of this science to benefit academic institutions, start-ups, SMEs and larger established companies.

As leaders of the Enabling Technologies work stream of the KTN Microbiome Innovation Network, Eagle Genomics was chosen to consult with and represent voices from the highly diverse and dynamic UK microbiome technology landscape. Speaking about the opportunity to contribute to this influential report, Eagle Genomics CEO Anthony Finbow commented:

Anthony Finbow CEO Eagle Genomics"We are delighted to have been invited to lead the Enabling Technologies work stream of the Microbiome Innovation Network, to represent the truly pioneering UK microbiome community. We hope the creation of this strategic roadmap will generate momentum and enhance the UK's rightful position as a leading microbiome authority, helping to address some of the global grand challenges of our age."

As the report reveals, the UK has a world-leading position in the science of the microbiome especially as it relates to human health and wellness but also a strong position within the animal and plant-based agriculture sectors, too. Moreover, the UK also has some of the world’s leading pharmaceutical, consumer health and wellness and agri-tech companies, a biotech ecosystem that is one of the most successful in the world, a supportive environment for life sciences and biotech start-ups and scale-ups and a constructive regulatory environment.

There are 12 distinct sections within this report, which summarise the current state of microbiome research, business and growth opportunities within each sector. These are:

  • Intestinal Microbiome Transfer
  • Live Biotherapeutic Products & other Therapeutic Modalities
  • Personal Care & Hygiene
  • Nutrition & Wellbeing
  • Animal Health & Nutrition
  • AgriFood & Nutrition – Crop & Soil Health
  • Regulatory
  • Manufacturing
  • Biobanking
  • Enabling Technologies
  • Diagnostics
  • Intellectual property

Find out more and download the full report here